HIMELSTEIN JAKE
Known title: President, BAMKO, LLCCIK: 0001870882
HIMELSTEIN JAKE's purchase track record
HIMELSTEIN JAKE has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/14/2024 | SGC | $26K | +28.9% | +16.0% | +10.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| SGC | ▼ Sell | Tax Withholding | 2,134 | $28K | 7/1/2026 | View on chart |
| SGC | ▼ Sell | Tax Withholding | 2,134 | $22K | 7/1/2025 | View on chart |
| SGC | ▲ Buy | Grant | 100,000 | — | 11/4/2024 | View on chart |
| SGC | ▲ Buy | Open Market | 2,000 | $26K | 8/14/2024 | View on chart |
| SGC | ▼ Sell | Tax Withholding | 6,401 | $121K | 7/1/2024 | View on chart |
| SGC | ▲ Buy | Option Exercise | 7,000 | $77K | 3/18/2024 | View on chart |
| SGC | ▼ Sell | Open Market | 7,000 | $110K | 3/18/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
SGC Stock Moves 2.27% Amidst Bullish Wall Street Views
Superior Group of Companies stock recently moved 2.27%, a shift that coincides with reports of bullish sentiment from Wall Street analysts. The company currently trades within a 52-week range of $8.30 to $14.59, with an average analyst target price of $18.00. This movement is notable given the stock's high beta status, which often indicates greater volatility compared to the broader market.
SGC Stock Moves 2.27% Amidst Bullish Wall Street Views. Superior Group of Companies stock recently moved 2.27%, a shift that coincides with reports of bullish sentiment from Wall Street analysts. The company currently trades within a 52-week range of $8.30 to $14.59, with an average analyst target price of $18.00. This movement is notable given the stock's high beta status, which often indicates greater volatility compared to the broader market.